Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FosB proto-oncogene, AP-1 transcription factor subunit (FOSB), encodes a leucine zipper transcription factor that dimerizes with JUN family members to form the AP-1 complex. This complex binds to specific DNA motifs (TRE: 5'-TGAG/CTCA-3') in the promoter regions of target genes, regulating their transcription. FOSB is critical for cellular proliferation, differentiation, and transformation; it is rapidly induced by extracellular stimuli and plays roles in neurogenesis, learning, memory, and nurturing behavior. A notable splice variant, ΔFosB, accumulates in the brain after chronic stressors (including drugs of abuse), mediating long-term neuroadaptations and addiction-related phenotypes. FOSB/AP-1 activity is implicated in several cancers, including leukemia, and regulates genes linked to inflammation, apoptosis, and cell survival. The AP-1 complex has been considered challenging to target pharmacologically, but new approaches exploit unique structural features such as a redox switch within ΔFosB to achieve specificity[1][2][3][4][6].
Drugs and stimuli induce FosB/ΔFosB through chronic cellular stress, which subsequently alters gene transcription and neuroplasticity. Small molecules may target the cysteine-based redox switch critical for DNA binding and transcriptional activity of ΔFosB. Changes in FOSB activity modulate downstream genes that regulate reward, learning, cell survival, proliferation, and inflammation.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FosB proto-oncogene, AP-1 transcription factor subunit (FOSB).